Qingdao Haier Biomedical Co Ltd (688139) — Free Cash Flow Generation Index
Qingdao Haier Biomedical Co Ltd (688139) has a Free Cash Flow Generation Index of -6.36x as of June 2023. Free cash flow of CN¥-46.60 Million represents -6% of operating cash flow (CN¥7.33 Million). See Qingdao Haier Biomedical Co Ltd (688139) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Qingdao Haier Biomedical Co Ltd Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Qingdao Haier Biomedical Co Ltd across 10 annual periods. Explore 688139 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Qingdao Haier Biomedical Co Ltd (2016–2025)
Year-by-year Free Cash Flow Generation Index for Qingdao Haier Biomedical Co Ltd. For the full company profile including market capitalisation, see market cap of Qingdao Haier Biomedical Co Ltd.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | CN¥148.64 Million | CN¥267.89 Million | CN¥119.25 Million | ▼ -1.9% |
| 2024 | 0.57x | CN¥164.96 Million | CN¥291.67 Million | CN¥126.70 Million | ▲ +95.6% |
| 2023 | 0.29x | CN¥72.08 Million | CN¥249.26 Million | CN¥177.18 Million | ▼ -45.9% |
| 2022 | 0.53x | CN¥338.18 Million | CN¥632.43 Million | CN¥294.24 Million | ▼ -12.6% |
| 2021 | 0.61x | CN¥387.11 Million | CN¥632.43 Million | CN¥204.69 Million | ▼ -29.8% |
| 2020 | 0.87x | CN¥607.63 Million | CN¥696.62 Million | CN¥88.99 Million | ▲ +118.3% |
| 2019 | 0.40x | CN¥112.09 Million | CN¥280.49 Million | CN¥168.40 Million | ▼ -25.3% |
| 2018 | 0.53x | CN¥79.67 Million | CN¥149.00 Million | CN¥69.33 Million | ▼ -34.6% |
| 2017 | 0.82x | CN¥121.35 Million | CN¥148.32 Million | CN¥26.98 Million | ▼ -23.2% |
| 2016 | 1.07x | CN¥235.22 Million | CN¥220.72 Million | CN¥14.50 Million | — |